Six comp meds among therapies in new depression treatment guidelines

New clinical practice guidelines issued this month by the Royal Australian and New Zealand College of Psychiatry name omega 3 fatty acids and St John’s Wort among evidence-based complementary therapies used in the management of mood disorders. According to a media statement from RANZCP, the 'Clinical Practice Guidelines for Mood Disorders' bring together the most up-to-date evidence available internationally for treatment of these conditions and will be useful for psychiatrists, psychologists and all specialties within mental health.

To continue reading this article, please Log In or Sign Up for access.